| Coping with strong translational non-crystallographic symmetry and extreme anisotropy in molecular … | | homo-4-mer | 8-188 | 100 | 4×MG; 4×GNP; |
|
| Fusion hSlp2-a_Rab27A bound to covalent hit fragment IMP-1721 | | homo-2-mer | 1-188 | 98.91 | 2×GNP; 12×GOL; 2×WTK; 2×MG; |
|
| Fusion hSlp2-a_Rab27A bound to covalent hit fragment IMP-1704 | | homo-2-mer | 1-188 | 98.91 | 7×GOL; 2×GNP; 2×WTU; 2×MG; |
|
| Fusion hSlp2-a_Rab27A non-covalent complex with hit fragment IMP-1704 | | homo-2-mer | 1-188 | 98.35 | 4×WT6; 2×GNP; 3×GOL; 2×MG; |
|
| Rab27a fusion with Slp2a-RBDa1 effector covalent adduct with CA1 in C188 | | homo-2-mer | 1-188 | 98.91 | 2×06D; 2×GNP; 2×MG; 8×GOL; |
|
| Crystal structure of the Rab27a fusion with Slp2a-RBDa1 effector for SF4 pocket drug targeting | | homo-2-mer | 1-188 | 98.32 | 2×GNP; 2×MG; |
|
| Rab27a fusion with Slp2a-RBDa1 effector covalent adduct with CB1 in C123 | | homo-2-mer | 1-188 | 98.92 | 2×GNP; 2×MG; 9×GOL; 2×05Y; |
|
| Fusion hSlp2-a_Rab27A non-covalent complex with compound IMP-2505 | | homo-2-mer | 1-188 | 98.36 | 2×GNP; 2×WTB; 10×GOL; 2×MG; |
|
| Fusion hSlp2-a_Rab27A bound to covalent hit fragment IMP-1712 | | homo-2-mer | 1-188 | 98.88 | 2×GNP; 4×GOL; 2×WTO; 2×MG; |
|